The effect of propylene glycol on antipyrine clearance in humans. 1987

E B Nelson, and J M Egan, and D R Abernethy

To evaluate the potential interaction of propylene glycol on hepatic drug oxidation, antipyrine disposition was measured in 10 healthy subjects who received 1.2 gm antipyrine alone on one occasion and 1.2 gm antipyrine with propylene glycol on a second occasion. Propylene glycol was given as a 5 ml dose every 4 hours during the 48 hours of the study. Propylene glycol had no effect on antipyrine half life (11.7 hours control vs. 12.1 hours treatment), clearance (42.6 vs. 39.2 ml/min), or volume of distribution (42.1 vs 41.9 L). At a dose similar to that used as a vehicle for administration of other drugs, propylene glycol had no significant effect on antipyrine clearance in humans.

UI MeSH Term Description Entries
D008297 Male Males
D011409 Propylene Glycols Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations. Propanediols,Glycols, Propylene
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000983 Antipyrine An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29) Phenazone,Anodynin,Pyramidone
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D014677 Pharmaceutical Vehicles A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986) Pharmaceutical Vehicle,Vehicle, Pharmaceutical,Vehicles, Pharmaceutical

Related Publications

E B Nelson, and J M Egan, and D R Abernethy
June 1978, Circulation,
E B Nelson, and J M Egan, and D R Abernethy
January 1991, Food additives and contaminants,
E B Nelson, and J M Egan, and D R Abernethy
January 1998, European journal of applied physiology and occupational physiology,
E B Nelson, and J M Egan, and D R Abernethy
May 1986, International journal of clinical pharmacology, therapy, and toxicology,
E B Nelson, and J M Egan, and D R Abernethy
January 1951, Bollettino dell'Istituto sieroterapico milanese,
E B Nelson, and J M Egan, and D R Abernethy
December 1988, British journal of clinical pharmacology,
E B Nelson, and J M Egan, and D R Abernethy
November 1986, British journal of clinical pharmacology,
E B Nelson, and J M Egan, and D R Abernethy
March 2010, Chemical senses,
E B Nelson, and J M Egan, and D R Abernethy
November 1982, British journal of clinical pharmacology,
E B Nelson, and J M Egan, and D R Abernethy
January 1983, Journal of clinical pharmacology,
Copied contents to your clipboard!